Experts create tool to help doctors avoid prescribing drugs to treat other drugs’ side effects
Medications are effective and powerful treatment options for protecting and advancing human health – but, if taken incorrectly, they can also cause harm, particularly among older adults who are taking multiple medications over long periods of time.
That’s why experts at the University of Toronto’s Leslie Dan Faculty of Pharmacy and Women’s College Hospital have led an effort to create a new tool for prescribers to identify, prevent and manage potentially inappropriate prescribing practices known as “prescribing cascades.”
“Prescribing cascades occur when a drug is prescribed to manage the side effects of another drug – often when a side effect is misinterpreted as a new medical condition,” says Lisa McCarthy, an expert in deprescribing and associate professor at the Leslie Dan Faculty of Pharmacy.
“Sometimes it makes sense to introduce a new drug to treat side-effects of another, but sometimes the prescriber doesn’t recognize that what they are seeing is, in fact, a drug-induced effect, and this can lead to inappropriate and potentially harmful prescribing.”
Inappropriate medication use as a result of prescribing cascades can put people at unnecessary risk of adverse drug events, reduced quality of life, as well as additional costs to individuals and health care systems.
To tackle the issue, McCarthy and her collaborators created a tool called ThinkCascades, which identifies nine clinically important prescribing cascades that affect older people when treating for common conditions such as anxiety, insomnia, hypertension or urinary incontinence.
The tool was recently presented in an article published in the journal Drugs & Aging.
"By identifying nine clinically important prescribing cascades, this tool helps clinicians recognize other prescribing cascades when managing polypharmacy,” says Paula Rochon, a senior scientist at Women’s College Research Institute, professor in the department of medicine in the Temerty Faculty of Medicine and Institute of Health Policy, Management and Evaluation at the Dalla Lana School of Public Health and founding director of the Women’s Age Lab based at Women’s College Hospital in Toronto.
“If we adjust our thinking to focus attention on raising awareness about prescribing cascades when reviewing medications, we can then work towards optimizing therapies and reducing medication harm for older adults, particularly women.”
While the research team notes there are many instances of prescribing cascades across health care globally, the nine included in the tool were selected by engaging a multidisciplinary panel of more than 30 clinicians from six countries with expertise in geriatric pharmacotherapy.
“Many clinicians struggle to identify prescribing cascades both conceptually and in clinical practice, which makes them underrecognized contributors to medication-related harm,” says McCarthy, who is also a clinician scientist at Trillium Health Partners. “In many ways, it’s really a problem that nobody sees. And when multiple prescribers are involved, responsibility for appropriate prescribing and patient education may also be unclear.”
But McCarthy notes there is growing awareness about the extent of preventable medication-related harm with the World Health Organization (WHO) identifying medication safety as the theme for its World Patient Safety Day, which was held Sept. 17. In addition to raising global awareness of the high burden of medication-related harm, WHO’s World Patient Safety Day aims to empower patients and families to be actively involved in the safe use of medications.
McCarthy says such involvement is an important aspect of reducing harm.
“We’ve seen that it’s not really on medical professionals’ radars to commonly think about drug-induced signs and symptoms, and so it becomes even more important for patients and families to understand their medications and to be prepared to ask, ‘Is what I’m experiencing related to my medication?’
“As health-care professionals, we need to be more aware and open to these discussions.”